H. Sugimura et al., CYTOCHROME-P-450 IA1 GENOTYPE IN LUNG-CANCER PATIENTS AND CONTROLS INRIO-DE-JANEIRO, BRAZIL, Cancer epidemiology, biomarkers & prevention, 3(2), 1994, pp. 145-148
MspI restriction fragment length polymorphism in cytochrome P-450 IA1
(CypIA1) gene, which has been associated with lung cancer susceptibili
ty in Japanese, was studied in persons from Rio de Janeiro, in the fra
mework of a hospital-based, age, race (black or nonblack), and gender-
matched case-control study (n = 222; 110 cases and 112 controls). Cont
rary to the hypothesis, there was no difference in the frequency of th
e C genotype (MspI site-present homozygous), even after racial breakdo
wn. There were no significant differences between cases and controls w
hen categorized according to tobacco consumption. The lifetime quantit
y of tobacco smoked was not different among lung cancer patients with
three different genotypes (A, MspI site-absent, homozygous; B, heteroz
ygote; and C). The background frequency of the MspI polymorphism C gen
otype is a little less than 10%, similar to that of the Japanese healt
hy population. The CypIA1 MspI polymorphism itself does not seem to be
related to susceptibility to bronchial carcinogenesis in this area.